Friday, September 20, 2024
Login
Subscribe
Unicorns
Investors
Analysis
Sectors
Agritech
Ecommerce
Edtech
Fintech
Policy
SaaS
Unicorns
Investors
Analysis
Sectors
Subscribe
Login
Unicorns
Investors
Analysis
Sectors
Agritech
Ecommerce
Edtech
Fintech
Policy
SaaS
Pharmaceuticals Drugs Medicines
Healthcare Start-Up Leucine Rich Bio Secures Funds In Pre-Series A Funding Round
20/10/2023
The company witnessed 20 per cent YoY growth in 2022-23, while the quarter-on-quarter growth was 30 per cent in the second quarter of the financial year 2023-24